title: Augmented insulinotropic action of arachidonic acid through the lipoxygenase pathway in the obese Zucker rat.
abstract: OBJECTIVE
  The metabolism of arachidonic acid (AA) has been shown to be altered in severe insulin resistance that is present in obese (fa/fa) Zucker rats. We examined the effects and mechanism of action of AA on basal and glucose-stimulated insulin secretion in pancreatic islets isolated from obese (fa/fa) Zucker rats and their homozygous lean (Fa/Fa) littermates.
  
  
  METHODS
  Islets were isolated from 10- to 12-week-old rats and incubated for 45 minutes in glucose concentrations ranging from 3.3 to 16.7 mM with or without inhibitors of the cyclooxygenase or lipoxygenase pathways. Medium insulin concentrations were measured by radioimmunoassay, and islet production of the 12-lipoxygenase metabolite, 12-hydroxyeicosatetraenoic acid (12-HETE), was measured by enzyme immunoassay.
  
  
  RESULTS
  In islets from lean animals, AA stimulated insulin secretion at submaximally stimulatory glucose levels (<11.1 mM) but not at 16.7 mM glucose. In contrast, in islets derived from obese rats, AA potentiated insulin secretion at all glucose concentrations. AA-induced insulin secretion was augmented in islets from obese compared with lean rats at high concentrations of AA in the presence of 3.3 mM glucose. Furthermore, the inhibitor of 12-lipoxygenase, esculetin (0.5 microM), inhibited AA-stimulated insulin secretion in islets from obese but not lean rats. Finally, the islet production of the 12-HETE was markedly enhanced in islets from obese rats, both in response to 16.7 mM glucose and to AA.
  
  
  CONCLUSIONS
  The insulin secretory response to AA is augmented in islets from obese Zucker rats by a mechanism related to enhanced activity of the 12-lipoxygenase pathway. Therefore, augmented action of AA may be a mechanism underlying the adaptation of insulin secretion to the increased demand caused by insulin resistance in these animals.
authors.affiliation: Department of Medicine, Lund University, Malmö, Sweden. bo.ahren@medforsk.mas.lu.se
authors.forename: B
authors.initials: B
authors.lastname: Ahrén
authors.forename: L J
authors.initials: LJ
authors.lastname: Magrum
authors.forename: P J
authors.initials: PJ
authors.lastname: Havel
authors.forename: S F
authors.initials: SF
authors.lastname: Greene
authors.forename: S D
authors.initials: SD
authors.lastname: Phinney
authors.forename: P R
authors.initials: PR
authors.lastname: Johnson
authors.forename: J S
authors.initials: JS
authors.lastname: Stern
mesh_terms: D000818:Animals; D016718:Arachidonic Acid / Q000378:metabolism* / Q000494:pharmacology; D002478:Cells, Cultured; D005947:Glucose / Q000378:metabolism; D007328:Insulin / Q000378:metabolism* / Q000494:pharmacology; D000078790:Insulin Secretion; D007515:Islets of Langerhans / Q000378:metabolism*; D008084:Lipoxygenase / Q000378:metabolism*; D008297:Male; D009765:Obesity / Q000503:physiopathology*; D051381:Rats; D011924:Rats, Zucker
chemical_list: D007328:Insulin; D016718:Arachidonic Acid; D008084:Lipoxygenase; D005947:Glucose